ConvaTec Group Plc

Symbol: CNVVF




Market price today

  • 42.7954

    P/E Ratio

  • -9.5576

    PEG Ratio

  • 7.51B

    MRK Cap

  • 0.00%

    DIV Yield

ConvaTec Group Plc (CNVVF) Stock Price & Analysis

Shares Outstanding


Gross Profit Margin


Operating Profit Margin


Net Profit Margin


Return on Assets


Return on Equity


Return on Capital Employed


Company general description and statistics

Sector: Healthcare
Industry: Medical - Instruments & Supplies
CEO:Mr. Karim Bitar
Full-time employees:10136
Address:3 Forbury Place

ConvaTec Group Plc develops, manufactures, and markets medical products and technologies worldwide. It offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, immobility, and venous disease, as well as from traumatic injury, burns, invasive surgery, and other causes. The company also provides devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, bladder cancer, obesity, and other causes. In addition, it offers continence and critical care products, including intermittent urinary catheters; and products for people with urinary continence issues related to spinal cord injuries, multiple sclerosis, spina bifida, and other urological disorders, as well as devices and products used in intensive care units and hospital settings. Further, the company provides advanced systems for managing acute fecal incontinence, as well as for monitoring urine production output and intra-abdominal pressure; and various disposable medical devices, such as wound drainage systems, urine collection bags and catheters, airway management and oxygen/aerosol therapy devices, suction handles and tubes, gastroenterology tubes, and securement devices. Additionally, it offers disposable infusion sets to manufacturers of insulin pumps for diabetes, as well as similar pumps that are used in continuous infusion treatments for other conditions; and various products to hospital and home healthcare markets. The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers. It serves a range of customers, including healthcare providers, patients, and manufacturers. The company was founded in 1978 and is headquartered in Reading, the United Kingdom.

General Outlook

In simple terms, ConvaTec Group Plc has 2038.815 M shares that people are buying and selling right now. When we look at how much money they make before expenses, they keep 0.544% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is 0.124%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of 0.047%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust 0.047% return, is a testament to ConvaTec Group Plc's adeptness in optimizing resource deployment. ConvaTec Group Plc's utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 0.166%. Furthermore, the proficiency of ConvaTec Group Plc in capital utilization is underscored by a remarkable 0.148% return on capital employed.

Stock Prices

ConvaTec Group Plc's stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $3.1, while its low point bottomed out at $3.1. This variance in figures offers investors a lucid insight into the roller-coaster ride that is ConvaTec Group Plc's stock market.

Liquidity Ratios

Analyzing CNVVF liquidity ratios reveals its financial health of the firm. The current ratio of 162.19% gauges short-term asset coverage for liabilities. The quick ratio (85.81%) assesses immediate liquidity, while the cash ratio (20.53%) indicates cash reserves.

Current Ratio162.19%
Quick Ratio85.81%
Cash Ratio20.53%

Profitability Ratios

CNVVF profitability indicators offer a lens into its earnings landscape. A pretax profit margin of 6.51% underscores its earnings before tax deductions. The effective tax rate stands at 28.44%, revealing its tax efficiency. The net income per EBT, 71.56%, and the EBT per EBIT, 52.38%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of 12.43%, we grasp its operational profitability.

Pretax Profit Margin6.51%
Effective Tax Rate28.44%
Net Income per EBT71.56%
EBT per EBIT52.38%
EBIT per Revenue12.43%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 1.62, it details the span from stock purchase to revenue. The 1 days it takes to settle debts showcases its creditor relations.

Days of Sales Outstanding86
Days of Inventory Outstanding84
Operating Cycle117.64
Days of Payables Outstanding82
Cash Conversion Cycle35
Receivables Turnover10.80
Payables Turnover4.44
Inventory Turnover4.35
Fixed Asset Turnover6.90
Asset Turnover1.02

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, 0.28, and free cash flow per share, 0.16, depict cash generation on a per-share basis. The cash per share value, 0.05, showcases liquidity position. A payout ratio of 1.09 highlights the portion of earnings distributed as dividends. Lastly, the operating cash flow sales ratio, 0.15, offers insight into cash flow relative to sales.

Operating Cash Flow per Share0.28
Free Cash Flow per Share0.16
Cash per Share0.05
Payout Ratio1.09
Operating Cash Flow Sales Ratio0.15
Free Cash Flow to Operating Cash Flow Ratio0.57
Cash Flow Coverage Ratio0.47
Short Term Coverage Ratio28.05
Capital Expenditure Coverage Ratio2.33
Dividend Paid and Capex Coverage Ratio1.31
Dividend Payout Ratio0.02

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 33.59%, highlights its total liabilities relative to assets. With a debt-equity ratio of 0.74, we discern the balance between debt and equity financing. The long-term debt to capitalization, 42.02%, and total debt to capitalization, 42.43%, ratios shed light on its capital structure. An interest coverage of 3.23 indicates its ability to manage interest expenses.

Debt Ratio33.59%
Debt Equity Ratio0.74
Long Term Debt to Capitalization42.02%
Total Debt to Capitalization42.43%
Interest Coverage3.23
Cash Flow to Debt Ratio0.47
Company Equity Multiplier2.19

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 1.08, provides a glimpse into top-line earnings distributed across each share. Net income per share, 0.06, reflects the portion of profit attributed to each share. The book value per share, 0.83, represents the net asset value distributed per share, while the tangible book value per share, -0.27, excludes intangible assets.

Revenue Per Share1.08
Net Income Per Share0.06
Book Value Per Share0.83
Tangible Book Value Per Share-0.27
Shareholders Equity Per Share0.83
Interest Debt Per Share0.65
Capex Per Share-0.06

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, 5.86%, indicates top-line expansion, while the gross profit growth, 8.99%, reveals profitability trends. EBIT growth, 41.24%, and operating income growth, 41.24%, offer insights into operational profitability progression. The net income growth, 107.15%, showcases bottom-line expansion, and the EPS growth, 114.43%, measures the growth in earnings per share.

Revenue Growth5.86%
Gross Profit Growth8.99%
EBIT Growth41.24%
Operating Income Growth41.24%
Net Income Growth107.15%
EPS Growth114.43%
EPS Diluted Growth115.56%
Weighted Average Shares Growth0.73%
Weighted Average Shares Diluted Growth0.60%
Dividends per Share Growth27.74%
Operating Cash Flow Growth30.73%
Free Cash Flow Growth71.60%
10-Year Revenue Growth per Share16.09%
5-Year Revenue Growth per Share16.09%
3-Year Revenue Growth per Share13.15%
10-Year Operating CF Growth per Share-11.39%
5-Year Operating CF Growth per Share-11.39%
3-Year Operating CF Growth per Share-9.95%
10-Year Net Income Growth per Share1185.48%
5-Year Net Income Growth per Share1185.48%
3-Year Net Income Growth per Share13.15%
10-Year Shareholders Equity Growth per Share4.69%
5-Year Shareholders Equity Growth per Share4.69%
3-Year Shareholders Equity Growth per Share-1.16%
10-Year Dividend per Share Growth per Share37.18%
5-Year Dividend per Share Growth per Share37.18%
3-Year Dividend per Share Growth per Share76.07%
Receivables Growth2.51%
Inventory Growth17.41%
Asset Growth3.24%
Book Value per Share Growth4.24%
Debt Growth0.80%
R&D Expense Growth22.33%
SGA Expenses Growth0.88%

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 7,479,654,311.24, captures the company's total value, considering both debt and equity. Income quality, 2.76, assesses the reliability of reported earnings. The sales, general, and administrative to revenue ratio, 0.10, gauges operational efficiency, while the research and development to revenue, 5.13%, highlights investment in innovation. The ratio of intangibles to total assets, 60.24%, indicates the value of non-physical assets, and capex to operating cash flow, -35.93%, measures reinvestment capability.

Enterprise Value7,479,654,311.24
Income Quality2.76
Sales General and Administrative to Revenue0.10
Research and Development to Revenue5.13%
Intangibles to Total Assets60.24%
Capex to Operating Cash Flow-35.93%
Capex to Revenue-6.03%
Capex to Depreciation-60.15%
Stock-Based Compensation to Revenue0.67%
Graham Number1.09
Return on Tangible Assets8.84%
Graham Net Net-0.71
Working Capital333,128,962
Tangible Asset Value-543,790,069
Net Current Asset Value-1,149,374,803
Invested Capital1
Average Receivables345,419,483
Average Payables367,375,580
Average Inventory366,220,356
Days Sales Outstanding58
Days Payables Outstanding143
Days of Inventory On Hand146

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 4.46, and the price to book ratio, 4.46, reflect the market's valuation relative to the company's book value. The price to sales ratio, 1.99, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, 22.73, and price to operating cash flows, 12.99, gauge market valuation against cash flow metrics.

Price Book Value Ratio4.46
Price to Book Ratio4.46
Price to Sales Ratio1.99
Price Cash Flow Ratio12.99
Price Earnings to Growth Ratio-9.56
Enterprise Value Multiple7.54
Price Fair Value4.46
Price to Operating Cash Flow Ratio12.99
Price to Free Cash Flows Ratio22.73
Price to Tangible Book Ratio3.71
Enterprise Value to Sales3.41
Enterprise Value Over EBITDA14.59
EV to Operating Cash Flow20.31
Earnings Yield2.08%
Free Cash Flow Yield3.76%
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of ConvaTec Group Plc (CNVVF) on the PNK in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is 42.795 in 2024.

What is the ticker symbol of ConvaTec Group Plc stock?

The ticker symbol of ConvaTec Group Plc stock is CNVVF.

What is company IPO date?

IPO date of ConvaTec Group Plc is 2017-03-07.

What is company current share price?

Current share price is 3.685 USD.

What is stock market cap today?

The market cap of stock today is 7513031613.000.

What is PEG ratio in 2024?

The current -9.558 is -9.558 in 2024.

What is the number of employees in 2024?

In 2024 the company has 10136.